Major targets are cell analysis (2 billion) and molecular diagnostics (3,3 billion)
Nikkei Biotech, March 27, 2014
Shimadzu Corporation aims at sales of 5,7 billion Yen for molecular diagnostics by 2017
Window to Japan
Window to Japan
Major targets are cell analysis (2 billion) and molecular diagnostics (3,3 billion)
Nikkei Biotech, March 27, 2014